EV/EBITDA
-2.14
+0.06+2.73%
Thu, 28 Nov 2024 00:53:03 GMT
Summary:
Allogene Therapeutics EV/EBITDA is currently -2.14, with a rise of +0.06 (+2.73%) during the most recent trading day. Over the past year, it has dropped by -0.75 (-53.96%). ALLO EV/EBITDA is now -64.62% below its all-time high of -1.30.ALLO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | +2.7% |
1 m1 month | +0.5% |
3 m3 months | -15.1% |
6 m6 months | -2.9% |
ytdytd | -15.1% |
1 y1 year | -54.0% |
5 y5 years | +89.3% |
ALLO EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -1.78 | -20.2% | -2.74 | +21.9% |
3 m | 3 months | -1.64 | -30.5% | -2.74 | +21.9% |
6 m | 6 months | -1.40 | -52.9% | -2.74 | +21.9% |
1 y | 1 year | -1.30 | -64.6% | -3.20 | +33.1% |
3 y | 3 years | -1.30 | -64.6% | -12.26 | +82.5% |
5 y | 5 years | -1.30 | -64.6% | -30.84 | +93.1% |
alltime | all time | -1.30 | -64.6% | -30.84 | +93.1% |
Allogene Therapeutics EV/EBITDA History
Date | Value |
---|---|
2024 | -2.14(+15.1%) |
2023 | -1.86(-37.2%) |
2022 | -2.96(-75.2%) |
Date | Value |
---|---|
2021 | -11.95(-12.3%) |
2020 | -13.62(-13.6%) |
2019 | -15.77(+1.5%) |
2018 | -15.53 |
FAQ
- What is Allogene Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Allogene Therapeutics?
- What is ALLO EV/EBITDA year-to-date change?
- What is Allogene Therapeutics EV/EBITDA year-on-year change?
What is Allogene Therapeutics EV/EBITDA?
The current EV/EBITDA of ALLO is -2.14
What is the all time high EV/EBITDA for Allogene Therapeutics?
Allogene Therapeutics all-time high EV/EBITDA is -1.30
What is ALLO EV/EBITDA year-to-date change?
Allogene Therapeutics EV/EBITDA has changed by -0.28 (-15.05%) since the beginning of the year
What is Allogene Therapeutics EV/EBITDA year-on-year change?
Over the past year, ALLO EV/EBITDA has changed by -0.75 (-53.96%)